Brand name drug prices rose an average of 8% last year
Drugs catered to the elderly were especially likely to rise in cost.
Health Industry Embraces Monetary Incentive Program for Prescriptions
A new program, which provides a monetary incentive to patients to take their medication, is being studied in Philadelphia.
Blue Cross’ new prescription program proves to be controversial among customers
The health insurance company’s customers will soon have to choose between mail order and pharmacy for receiving their prescriptions.
If patients would take prescriptions as directed, the U.S. would save billions in health costs
So say U.S. researchers after conducting a study.
Blue Cross vs. Pharmacies battle illustrates biggest difficulty in healthcare reform
So says Wilkes-Barre’s The Citizens Voice.
Blue Cross of NEPA is making mail order prescriptions the default for its customers
“Studies have shown that many members intend to switch from retail to a home delivery pharmacy, yet do not follow through due to procrastination or forgetfulness. Select Home Delivery taps into this latent demand by engaging members in their health care and giving them an opportunity to make an educated decision,” said a statement from the company.
Group says prescription drug revenue growth will decline next year
Revenue will still increase, just not as much as in past years.
Bus for prescription assistance program will make rounds in PA during July
The “Help is Here Express” bus will tour Pennsylvania, to help those who struggle to pay for their prescription medications.
PhRMA: Medicaid carve-out would hurt patients & taxpayers
The Pharmaceutical Research and Manufacturers of America say that carving drug coverage out of the Medicaid program would disrupt treatment for patients, among other consequences.
How much will the federal government save with new prescription drug plan of action?
President Obama and other groups are praising pharmaceutical companies’ promise to lower drug prices for Medicare patients who fall into the coverage gap, but some Senates say that the government won’t benefit from the deal.